Lot · RR-RETA-2026Store 2–8°C · Keep Dry
Triple Agonist · GLP-1 / GIP / Glucagon
Retatrutide
Investigational triple-receptor agonist studied for metabolic pathway research.
- Formula
- C221H343N51O64
- Mol. Weight
- ≈4731 g/mol
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized
Available Configurations
Retatrutide · 10mg
$70
Retatrutide · 15mg
$95
Retatrutide · 20mg
$115
Retatrutide · 24mg
$130
/ Research Notes
Compound Profile
Retatrutide is a synthetic 39-amino-acid peptide engineered as a triple agonist of GLP-1, GIP, and glucagon receptors. Investigators use it in preclinical assays exploring receptor cross-talk, energy expenditure, and adipose signaling.
This compound is supplied strictly for in-vitro laboratory research. Not for human consumption, therapeutic, or diagnostic use.
HPLC Verified
≥99% purity
Mass-Spec Confirmed
MW verified
Sealed Vials
Tamper-evident packaging
Lyophilized
Sterile filled
